Net Cash Provided by (Used in) Operating Activities |
-1.44M |
USD |
+46.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
701K |
USD |
|
Q1 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
111K |
USD |
+1486% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
+257% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
15M |
shares |
+89.1% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.44M |
USD |
-57.6% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
5K |
USD |
-37.5% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
111M |
USD |
-2.4% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
112M |
USD |
-4.62% |
Q4 2023 |
FY 2023 |
Property, Plant and Equipment, Gross |
7.97M |
USD |
-77.5% |
Q2 2024 |
Q2 2024 |
Operating Lease, Liability, Current |
72K |
USD |
|
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
17K |
USD |
|
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
105M |
USD |
-4.06% |
Q4 2023 |
FY 2023 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
532K |
USD |
+110% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
430K |
USD |
-31.4% |
Q2 2024 |
Q2 2024 |